Synergistic induction of apoptosis in primary CD4+ T cells by macrophage-tropic HIV-1 and TGF-β1

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3360-3366

  Wang, J ^a   Guan, E ^a   Roderiquez, G ^a   Norcross, M A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 2; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; T LYMPHOCYTE SUBPOPULATION;

EID: 0035884837     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3360     Document Type: Article

References (71)

1. Programmed death of T cells in HIV-1 infection
2. + T cells from human immunodeficiency virus-infected asymptomatic individuals
3. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
4. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis
5. + T cells by a Fas-independent mechanism
6. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
7. HIV type 1 Tat protein enhances activation- but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals
8. HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95 (Fas)
9. + T lymphoid cells to apoptosis via functional up-regulation of the CD95/CD95 ligand pathway
10. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
11. + T cells in human-PBL-SCID mice by noncytopathic HIV isolates
12. Host factors in the pathogenesis of HIV disease
13. Host factors and the pathogenesis of HIV-induced disease
14. Inhibition of CCR5 expression by IL-12 through induction of β-chemokines in human T lymphocytes
15. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression
16. Role of transforming growth factor β in human disease
17. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
18. Increased levels of interferon-γ, (IFN-γ). IL-4 and transforming growth factor-β (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection
19. Macruphage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome
20. HIV-1 gp160 induces transforming growth factor-β production in human PBMC
21. Human astrocytes inhibit HIV-1 expression in monocyte-derived macrophages by secreted factors
22. The replicative restriction of lymphocytotropic isolates of HIV-1 in macrophages is overcome by TGF-β
23. Cytokines regulate expression and function of the HIV coreceptor CXCR4 on human mature dendritic cells
24. TGF-β reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors
25. + cell antiviral factor
26. Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage
27. In vitro effect of transforming growth factor-β on progression of HIV-1 infection in primary mononuclear phagocytes
28. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via down-regulation of c-Myc
29. TGF-β influences the life and death decisions of T lymphocytes
30. 2+ elevation and cyclosporin A synergistically induce TGF-β1-mediated apoptosis in lymphocytes
31. TGF β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκBα
32. Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines
33. Three distinct roles for TGF-β during intercellular induction of apoptosis: A review
34. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
35. The Fas death factor
36. Molecular characterization of mitochondrial apoptosis-inducing factor
37. Caspases: Enemies within
38. Caspases: The executioners of apoptosis
39. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
40. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
41. The proto-oncogene Bcl-2 and its role in regulating apoptosis
42. Regulation of lymphocyte survival by the bcl-2 gene family
43. Bcl-2 and Bcl-x: Regulatory switches for lymphoid death and survival
44. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax
45. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis
46. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation
47. Caspases: Controlling intracellular signals by protease zymogen activation
48. Emerging roles of caspase-3 in apoptosis
49. Interleukin-1β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection
50. Diminished spontaneous apoptosis in lymphocytes from human immunodeficieney virus-infected long-term nonprogressors
51. + T cells
52. Structural basis for the inhibition of caspase-3 by XIAP
53. Structural basis of caspase-7 inhibition by XIAP
54. Plasma membrane phospholipid asymmetry, precedes DNA fragmentation in different apoptotic cell models
55. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
56. Progression to the Glb phase of the cell cycle is required for completion of human immunodeficieney virus type 1 reverse transcription in T cells
57. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
58. Mitochondria and apoptosis
59. Mitochondrial control of nuclear apoptosis
60. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
61. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
62. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
63. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
64. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells
65. + T cells
66. Apoptosis-inducing factor (AIF): A ubiquitous mitochondrial oxidoruductase involved in apoptosis
67. + T lymphocytes is not mediated by Fas-Fas ligand
68. Fas ligand deficiency in HIV disease
69. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease
70. Up-regulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
71. The expression of Fas ligand by macrophages and its up-regulation by human immunodeficiency virus infection